Herpes simplex virus (HSV) is tested in two main ways: by swabbing an active sore or by drawing blood to look for antibodies. The best test depends on whether you currently have symptoms. If you have a visible sore or blister, a swab test gives the most reliable answer. If you don’t have symptoms but want to know your status, a blood test can detect past infection, though it comes with important accuracy limitations.
Swab Tests for Active Outbreaks
When you have a sore, blister, or area of broken skin that might be herpes, a clinician will swab the lesion and send the sample to a lab. There are two types of swab tests: viral culture and PCR (a DNA-based test). PCR is now the preferred method because it’s significantly more sensitive. In studies comparing the two, PCR detected HSV in about 86% of confirmed cases, while viral culture caught only about 43%. Both tests have near-perfect specificity, meaning a positive result is highly reliable regardless of which method is used.
Timing matters. Swabs should ideally be collected within 3 to 4 days of symptoms appearing, and no later than 7 days. Early in an outbreak, the sore contains the most virus. As it begins to crust over and heal, the amount of detectable virus drops sharply, increasing the chance of a false negative. If you suspect herpes, getting swabbed as soon as possible gives you the best shot at a clear answer.
A swab test also tells you which type you have. HSV-1 and HSV-2 behave differently over time (HSV-1 on the genitals recurs far less often than HSV-2), so knowing the type helps you understand what to expect going forward.
Blood Tests for HSV Antibodies
Blood tests detect antibodies your immune system produces after infection, not the virus itself. Type-specific IgG tests look for antibodies to a protein called glycoprotein G, which differs between HSV-1 and HSV-2. This allows the test to distinguish which type you carry. These tests are useful when you have no active sore to swab but want to know if you’ve been infected at some point.
The major limitation is the window period. After exposure, it can take up to 16 weeks or more for antibodies to reach detectable levels. Testing too early after a possible exposure often produces a falsely negative result. If your first test is negative but you had a recent exposure, retesting after several months gives a more reliable picture.
False Positives and Low-Positive Results
Blood tests for HSV have a well-documented false positive problem, particularly for HSV-2. Results are reported as an index value rather than a simple positive or negative. Values between 1.10 and 3.50 on the most widely used screening test fall into a “low positive” range where false positives are common. One study found that about 21% of HSV-2 results and 61% of HSV-1 results in that low-positive range were actually false positives.
Because of this, the CDC recommends a two-step process: an initial screening test followed by a second, more specific confirmatory test when results fall in that low-positive zone. If you receive a low-positive HSV-2 result, ask your provider about confirmatory testing before accepting the diagnosis. A result with an index value above 3.5 is much more likely to be a true positive.
Why Routine Screening Isn’t Recommended
You might assume that HSV testing is part of a standard STI panel, but it typically isn’t. The CDC does not recommend routine HSV-2 blood testing for the general population, including pregnant women. This surprises many people, but the reasoning comes down to the false positive rate. In a population where most people don’t have HSV-2, even a small false positive rate produces a large number of incorrect diagnoses relative to true ones. The psychological harm of a false diagnosis, combined with the test’s limitations, outweighs the benefit of screening people without symptoms.
Testing is generally recommended when you have symptoms that could be herpes, when a sexual partner has a known herpes diagnosis, or when you’re getting a comprehensive STI workup and specifically request it. In those situations, the prior probability of infection is higher, which makes the test results more meaningful.
At-Home Test Kits
Several companies sell home collection kits for herpes that involve mailing a blood sample to a lab. However, no at-home herpes test currently has FDA approval. The only FDA-cleared home STI tests cover HIV, syphilis, and a combined test for chlamydia, gonorrhea, and trichomoniasis. The American Sexual Health Association has flagged concerns that home herpes blood tests return a significant number of false positives, which can cause unnecessary distress. If you use a home kit and get a positive result, treat it as a screening result that needs confirmation through a clinician.
Testing for Herpes in the Brain and Spinal Cord
In rare cases, HSV can infect the brain (encephalitis) or the membranes around the spinal cord (meningitis). This is a medical emergency, and testing looks very different. Doctors perform a spinal tap to collect cerebrospinal fluid, then run a PCR test on that sample. This is the gold standard for diagnosing HSV in the central nervous system. The test detects viral DNA directly in the spinal fluid and can distinguish between HSV-1 (the more common cause of brain infections) and HSV-2 (more often linked to meningitis). This type of testing happens in a hospital setting and isn’t something you’d seek out on your own.
Which Test to Ask For
If you have an active sore, ask for a PCR swab test. It’s the most accurate option available and will tell you both whether it’s herpes and which type. Don’t wait for the sore to start healing.
If you have no symptoms but want to know your status, a type-specific IgG blood test is your option, but make sure at least 12 to 16 weeks have passed since any potential exposure. If the result comes back in the low-positive range (index value 1.10 to 3.50), request confirmatory testing before drawing conclusions. A negative result within a few weeks of exposure doesn’t rule anything out, and retesting later is worth doing if the concern remains.